BioSpace News Archive

Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery announced the successful first surgeries of the Spartan™ Stem and Logical™ Cup System for total hip arthroplasty.

VySpine, a spine innovation leader using differentiated materials and designs, announced today that it has received 510(k) clearance from the FDA for its VyPlate Anterior Cervical Plate System.

Abivax SA, a phase 3 clinical-stage biotechnology company developing novel therapies that modulate the immune system to treat chronic inflammatory diseases, viral infections, and cancer, announces a transition in the governance of its Board of Directors.

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Morgan Stanley 20th Annual Global Healthcare Conference.

Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, reported results for the first half of fiscal year 2022, for the period ended June 30, 2022.

Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that Dr. Richard Caruso, founder and former chairman and CEO of Integra LifeSciences passed away over the past weekend.

BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and related disorders, today provided a business update for the second quarter ended June 30, 2022 and reported on recent corporate developments.

Deepcell today announced the appointment of Kady Cooper as Head of People.

The Parkinson’s Foundation has announced an investment of $5.7 million in 33 grants to accelerate cutting-edge Parkinson’s disease research.

MCRA, LLC is pleased to announce the formation and expansion of its biocompatibility division, led by former FDA biocompatibility reviewer Robert A.